Department Of Pathology 2
51. Designing a multi-epitope vaccine targeting UPF0721 of meningitis-causing Salmonella enterica serovar Typhimurium strain L-4126 by utilizing immuno-informatics and in silico approaches
52. Robust Multiepitope Vaccine from Glycoproteins Against Human Metapneumovirus Genotypes A2a, A2b, and A2c by Utilizing Immunoinformatics and Reverse Vaccinology Approaches
53. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
54. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
55. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
56. Prevalence, incidence, mortality attributed to HIV in children under 5 years of age, and comparative analysis of health expenditure in central Asian countries
57. Pathophysiology of cardiovascular diseases and the role of vitamins, and herbal extracts in the reduction of cardiovascular risks
58. A Giant Diving Ranula Extending to the Skull Base in Pediatric Age
59. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
60. Targeting Cbx3/HP1γ Induces LEF-1 and IL-21R to Promote Tumor-Infiltrating CD8 T-Cell Persistence
61. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
62. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
63. Multimodal analysis suggests differential immuno-metabolic crosstalk in lung squamous cell carcinoma and adenocarcinoma
64. CRISPR revolution: Unleashing precision pathogen detection to safeguard public health and food safety
65. Smart technology for public health: reshaping the future of food safety
66. The burden of diseases, injuries, and risk factors by state in the USA, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
67. Induction of Apoptosis by Ethanol, Methanol, and Ethyl Acetate Extracts from Cyperus Rotundus Leaf on In Vitro Human Ovarian, Cervix, and Breast Cancer Cell Lines
68. Engineered antigen-specific regulatory T cells for autoimmune skin conditions
69. The relevance of vitamin D in the oral health of HIV infected patients
70. Elemental composition of hair as a marker for forensic human identification
71. Person identification using the composition of elements in human hair
72. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
73. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
74. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
75. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
76. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
77. Associations between pathological features and radioactive iodine-refractory recurrent papillary thyroid carcinoma: with mutation analysis using recurrent samples
78. BRAFV600E and TERT promoter mutations and their impact on recurrent papillary thyroid carcinoma progression
79. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
80. Multiplex immunohistochemical phenotyping of T cells in primary prostate cancer
81. Multiplex immunohistochemical phenotyping of T cells in primary prostate cancer
82. Multiplex immunohistochemical phenotyping of T cells in primary prostate cancer
83. Multiplex immunohistochemical phenotyping of T cells in primary prostate cancer
84. Multiplex immunohistochemical phenotyping of T cells in primary prostate cancer
85. Nonpharmaceutical interventions reduce the incidence and mortality of COVID-19: A study based on the survey from the International COVID-19 Research Network (ICRN)
86. Neuroprotective effects of magnesium: implications for neuroinflammation and cognitive decline
87. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
88. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
89. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
90. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
91. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
92. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
93. HBV S antigen evolution in the backdrop of HDV infection affects epitope processing and presentation
94. COVID-19 associated rhino-orbital-cerebral mucormycosis with underlying diabetes mellitus
95. Protective effect of dapagliflozin on lipopolysaccharide-induced acute lung injury via the SIRT-1/PGC-1α pathway
96. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
97. Temporal patterns of cancer burden in Asia, 1990–2019: a systematic examination for the Global Burden of Disease 2019 study
98. Temporal patterns of cancer burden in Asia, 1990–2019: a systematic examination for the Global Burden of Disease 2019 study
99. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019
100. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019
1 2 3